Liu P, Zhou Y, Dong X, Zheng B, Liang B, Liang R, et al
Trump announces plans to slim down cost of popular weight-loss drugs to $149 a month Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trumps most-favored nation pricing plan Bookmark CommentsGo to comments The Trump administration has reached a deal with two drug makers to lower prices of popular GLP-1 diabetes medications for Americans on Medicare and Medicaid as well as for those who purchase the drugs on the administrations forthcoming TrumpRx web site
Results showed that semaglutide cut heavy drinking days by about 41% after patients worked up to the full weekly dose compared to 26% for those taking the placebo, according to the study published Thursday in The Lancet
doi: 10.3350/cmh.2025.0744, 51
And WeightWatchers has indeed been trying to expand their audience: In 2019, they bought Kurbo, a childrens weight loss app